Publications by authors named "Massimo G Colombo"

Claim this Profile
P
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology.
Dana Ivancovsky Wajcman, Aina Nicolàs, Camila A Picchio, Lena van Selm, Geoffrey Dusheiko, Massimo G Colombo

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma.
Saleh A Alqahtani, Massimo G Colombo

World J Gastrointest Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating paediatric hepatitis C in the era of direct-acting antiviral agents.
Saleh A Alqahtani, Massimo G Colombo

Liver Int· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic capabilities and high-tech entrepreneurial ventures' performance in the aftermath of an environmental jolt.
Massimo G Colombo, Evila Piva, Anita Quas, Cristina Rossi-Lamastra

Long Range Plann· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions.
Massimo Giuseppe Colombo, Erkin Isakovich Musabaev, Umed Yusupovich Ismailov, Igor A Zaytsev, Alexander V Nersesov

World J Gastroenterol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.
Joseph D Tucker, Kathrine Meyers, John Best, Karyn Kaplan, Razia Pendse, Massimo G Colombo

BMC Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENTREPRENEURSHIP. Cash from the crowd.
Massimo G Colombo, Chiara Franzoni, Cristina Rossi-Lamastra

Science· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.
Pietro Andreone, Massimo G Colombo, Jeffrey V Enejosa, Iftihar Koksal, Peter Ferenci

Gastroenterology· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis